Skip to main content
. 2024 Sep 5;4(3):e859. doi: 10.52225/narra.v4i3.859

Figure 5.

Figure 5.

Molecular docking results of physalin + BCMA (A), withanolide + BCMA (B), physalin F + BCMA (C), withaphysalin A + BCMA (D), and belimumab + BCMA (E).